PL2882435T3 - Preparaty farmaceutyczne zawierające 3-(4-cynamylo-L-piperazynylo)-aminopochodne 3-formyloryfamycyny S - Google Patents
Preparaty farmaceutyczne zawierające 3-(4-cynamylo-L-piperazynylo)-aminopochodne 3-formyloryfamycyny SInfo
- Publication number
- PL2882435T3 PL2882435T3 PL13829445T PL13829445T PL2882435T3 PL 2882435 T3 PL2882435 T3 PL 2882435T3 PL 13829445 T PL13829445 T PL 13829445T PL 13829445 T PL13829445 T PL 13829445T PL 2882435 T3 PL2882435 T3 PL 2882435T3
- Authority
- PL
- Poland
- Prior art keywords
- formylrifamycin
- cinnamyl
- piperazinyl
- pharmaceutical formulations
- formulations containing
- Prior art date
Links
- 150000001412 amines Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Inorganic Chemistry (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BG11128812 | 2012-08-13 | ||
| PCT/BG2013/000041 WO2014026254A1 (en) | 2012-08-13 | 2013-08-09 | Pharmaceutical formulations containing 3-(4-cinnamyl-l-piperazinyl) amino derivatives of 3-formylrifamycin sv and 3-formylrifamycin s and a process of their preparation |
| EP13829445.9A EP2882435B8 (en) | 2012-08-13 | 2013-08-09 | Pharmaceutical formulations containing 3-(4-cinnamyl-L-piperazinyl) amino derivatives of 3-formylrifamycin S |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2882435T3 true PL2882435T3 (pl) | 2021-10-04 |
Family
ID=50101135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13829445T PL2882435T3 (pl) | 2012-08-13 | 2013-08-09 | Preparaty farmaceutyczne zawierające 3-(4-cynamylo-L-piperazynylo)-aminopochodne 3-formyloryfamycyny S |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US9682997B2 (pl) |
| EP (1) | EP2882435B8 (pl) |
| JP (2) | JP6400580B2 (pl) |
| KR (1) | KR102210848B1 (pl) |
| CN (2) | CN107840854A (pl) |
| BR (1) | BR112015002945B1 (pl) |
| CA (1) | CA2881958C (pl) |
| EA (1) | EA029363B1 (pl) |
| ES (1) | ES2876004T3 (pl) |
| HK (2) | HK1206980A1 (pl) |
| HU (1) | HUE054955T2 (pl) |
| IN (1) | IN2015DN02009A (pl) |
| MX (1) | MX2015001963A (pl) |
| PL (1) | PL2882435T3 (pl) |
| PT (1) | PT2882435T (pl) |
| UA (1) | UA120030C2 (pl) |
| WO (1) | WO2014026254A1 (pl) |
| ZA (1) | ZA201501268B (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2020102511A (ru) * | 2017-06-26 | 2021-07-27 | Биофер С.П.А. | Соединения пиридо-имидазо рифамицина в качестве антибактериального средства |
| TWI731295B (zh) * | 2019-01-24 | 2021-06-21 | 宏碁股份有限公司 | 顯示裝置以及控制顯示裝置的方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1478563A (en) | 1975-03-05 | 1977-07-06 | Lepetit Spa | Rifamycin derivatives |
| GR64108B (en) | 1977-04-15 | 1980-01-24 | Dso Pharmachim | Method for the preparation of azomethine-derivatives of rifamycin s.v |
| US4179439A (en) * | 1977-07-01 | 1979-12-18 | Intreprinderea De Antibiotice Iasi | Rifamycins and method for their preparation |
| US4193020A (en) | 1978-05-22 | 1980-03-11 | Sperry Rand Corporation | Phase lock control system with trajectory correction |
| JPS5738742A (en) * | 1980-08-21 | 1982-03-03 | Kawasaki Kasei Chem Ltd | Preparation of 1,4-dihydroanthraquinone |
| JPS5695190A (en) * | 1980-09-17 | 1981-08-01 | Intorepurinderea De Anteibiote | Manufacture of rifamycin derivative |
| IT1201963B (it) * | 1983-03-24 | 1989-02-02 | Prodotti Antibiotici Spa | Derivati delle rifamicine e procedimento per la loro preparazione |
| JPS6143132A (ja) * | 1984-08-06 | 1986-03-01 | Takeda Chem Ind Ltd | キノン誘導体，その製造法およびそれを含んでなる医薬組成物 |
| WO1987002361A1 (en) * | 1985-10-18 | 1987-04-23 | Ciba-Geigy Ag | Substituted 4-benzyl-piperazinyl compounds |
| IT1202424B (it) * | 1987-01-26 | 1989-02-09 | Prodotti Antibiotici Spa | Sali di un derivato rifamicinico |
| EP0284552A1 (de) * | 1987-03-06 | 1988-09-28 | Ciba-Geigy Ag | 4-Benzyl-piperazinyl-Hydrazone |
| BG48618A1 (en) | 1988-02-23 | 1991-04-15 | Nauchen Inst Promishlena Mikro | Method for preparing riphampycin |
| JPH02215716A (ja) * | 1989-02-08 | 1990-08-28 | Farmitalia Carlo Erba Spa | ３―（ｎ―ピペリジノメチル―アジノ）メチルリファマイシンｓを活性成分として含有する薬剤組成物 |
| US5095108A (en) | 1990-08-28 | 1992-03-10 | Technologichen Kombinat Za Promishlena Microbiologia | Non-solvated crystalline form "A" of 3-(4-cynnamyl-1-piperazinyl)iminomethylrifamycine SV and a method of its production |
| BG64021B1 (bg) | 1998-11-04 | 2003-10-31 | КОНСТАНТИНОВА Румяна | Натриева сол на 3-(4-цинамил-1-пиперазинил)-иминометил рифамицин и метод за получаването й |
| DE10015814A1 (de) * | 2000-03-30 | 2001-10-11 | Max Planck Gesellschaft | Arzneimittel zur Stimulierung der Leukopoese, zur Behandlung von Tumor- und Protozoenerkrankungen und Verfahren zu seiner Herstellung |
| DE10038101A1 (de) * | 2000-08-04 | 2002-02-14 | Degussa | Verfahren zur Herstellung von 2-(4-Methyl-3-pentenyl)-anthrachinon |
| UA80393C2 (uk) * | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
| CN101031572B (zh) * | 2004-07-22 | 2010-12-08 | 坎布里Ip风险投资有限合伙公司 | (r/s)利福霉素衍生物，它们的制备和药物组合物 |
| GB0505909D0 (en) * | 2005-03-23 | 2005-04-27 | Univ Leeds | Formulations |
-
2013
- 2013-08-09 KR KR1020157006421A patent/KR102210848B1/ko active IP Right Grant
- 2013-08-09 JP JP2015526838A patent/JP6400580B2/ja active Active
- 2013-08-09 HU HUE13829445A patent/HUE054955T2/hu unknown
- 2013-08-09 UA UAA201502014A patent/UA120030C2/uk unknown
- 2013-08-09 PL PL13829445T patent/PL2882435T3/pl unknown
- 2013-08-09 MX MX2015001963A patent/MX2015001963A/es unknown
- 2013-08-09 ES ES13829445T patent/ES2876004T3/es active Active
- 2013-08-09 CN CN201711346387.6A patent/CN107840854A/zh active Pending
- 2013-08-09 EA EA201590278A patent/EA029363B1/ru unknown
- 2013-08-09 CA CA2881958A patent/CA2881958C/en active Active
- 2013-08-09 BR BR112015002945-0A patent/BR112015002945B1/pt active IP Right Grant
- 2013-08-09 IN IN2009DEN2015 patent/IN2015DN02009A/en unknown
- 2013-08-09 EP EP13829445.9A patent/EP2882435B8/en active Active
- 2013-08-09 US US14/421,364 patent/US9682997B2/en active Active
- 2013-08-09 PT PT138294459T patent/PT2882435T/pt unknown
- 2013-08-09 WO PCT/BG2013/000041 patent/WO2014026254A1/en active Application Filing
- 2013-08-09 CN CN201380053241.6A patent/CN104736152B/zh active Active
-
2015
- 2015-02-25 ZA ZA2015/01268A patent/ZA201501268B/en unknown
- 2015-08-06 HK HK15107597.5A patent/HK1206980A1/xx unknown
-
2017
- 2017-06-14 US US15/622,880 patent/US9981985B2/en active Active
-
2018
- 2018-06-27 HK HK18108267.9A patent/HK1248691A1/zh unknown
- 2018-09-04 JP JP2018165179A patent/JP6694029B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1255336A1 (zh) | 藥物製劑及其製備方法 | |
| IL259921B (en) | A new stabilizing factor for pharmaceutical proteins | |
| SG10201609982PA (en) | Pharmaceutical formulations of tnf-alpha anitbodies | |
| HK1203812A1 (en) | Novel pharmaceutical formulations | |
| HRP20181896T1 (hr) | Farmaceutske formulacije | |
| HK1199821A1 (en) | Oral pharmaceutical composition | |
| EP2815753A4 (en) | ORAL PHARMACEUTICAL COMPOSITION | |
| ZA201502695B (en) | Stable pharmaceutical composition of peginterferon alpha-2b | |
| HK1188791A1 (zh) | 新型八氫噻吩並喹啉衍生物、包含所述衍生物的藥物組合物及它們的用途 | |
| HK1248691A1 (zh) | 3-甲酰基利福黴素sv的3-(4-肉桂基-1-呱嗪基)氨基衍生物的用途和製備方法 | |
| HK1209339A1 (en) | Pharmaceutical formulations | |
| HK1204945A1 (en) | Pharmaceutical formulation containing flupirtin | |
| EP2884963A4 (en) | STABLE PHARMACEUTICAL FORMULATION OF CABAZITAXEL | |
| IL233983A0 (en) | History of thiazolidinones, their preparation and pharmaceutical preparations containing them | |
| GB201211406D0 (en) | Pharmaceutical formulations | |
| GB201211403D0 (en) | Pharmaceutical formulations | |
| GB201111577D0 (en) | Pharmaceutical formulations |